南京科思化学股份有限公司 投资者关系活动资料 证券代码：300856 证券简称：科思股份 编号：2022-001 南京科思化学股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-------------------------|------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------| | | | 特定对象调研 □分析师会议 | | | □媒体采访 | □业绩说明会 | | 投资者关系活动 | □新闻发布会 □路演活动 | | | 类别 | □现场参观 | | | | □其他 | | | | 国海富兰克林基金 于军 | 杜飞、国信证券 张峻豪 王畅、华泰资 | | 参与单位名称及 人员姓名 | 管 朱南珏、德邦基金 基 ...

南京科思化学股份有限公司 投资者关系活动资料 投资者关系活动记录表 证券代码：300856 证券简称：科思股份 编号：2022-004 南京科思化学股份有限公司 | --- | --- | --- | |-------------------------|---------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------| | | | 特定对象调研 □分析师会议 | | | □媒体采访 | □业绩说明会 | | 投资者关系活动 | □新闻发布会 □路演活动 | | | 类别 | □现场参观 | | | | □其他 | | | | 银河基金 冯敏、兴业基金 | 朱宇轩、东吴证券 张家璇、东方基 | | | 金 邵子馨、德邦证券 | 易丁依、中金公司 徐卓楠、磐厚动量 张 | | 参与单 ...

Revenue and Profit Growth - Revenue for Q3 2022 reached ¥428,583,831.95, an increase of 82.53% year-over-year, and year-to-date revenue was ¥1,248,968,486.29, up 68.00% compared to the same period last year[6] - Net profit attributable to shareholders for Q3 2022 was ¥107,295,038.94, a significant increase of 324.77% year-over-year, with a year-to-date net profit of ¥254,151,849.99, up 127.42%[6] - Basic earnings per share for Q3 2022 was ¥0.6337, reflecting a 324.77% increase year-over-year, while year-to-date earnings per share was ¥1.5010, up 127.42%[7] - Total operating revenue for Q3 2022 reached CNY 1,248,968,486.29, a significant increase of 68.1% compared to CNY 743,434,726.62 in the same period last year[26] - Net profit for Q3 2022 was CNY 254,151,849.99, representing a 127.6% increase from CNY 111,752,283.93 in Q3 2021[28] - The company reported a total comprehensive income of CNY 257,001,887.93 for Q3 2022, compared to CNY 111,654,142.82 in the same quarter last year, indicating a growth of 130.0%[30] Cash Flow and Assets - Operating cash flow for the year-to-date period increased by 49.05%, totaling ¥170,595,204.38, primarily due to increased cash receipts from sales[11] - The cash inflow from operating activities totaled CNY 1,299,302,269.95, an increase of 53% compared to CNY 849,715,265.05 in the previous period[33] - The net cash flow from operating activities was CNY 170,595,204.38, up from CNY 114,457,262.44, representing a growth of 49%[33] - The ending balance of cash and cash equivalents reached CNY 418,160,682.63, significantly higher than CNY 47,678,860.97 at the end of the previous period[35] - Total assets as of the end of the reporting period were ¥2,112,983,861.79, representing a 15.08% increase from the end of the previous year[7] - As of September 30, 2022, the company's total current assets amounted to RMB 1,229,512,214.47, an increase from RMB 1,074,959,121.66 at the beginning of the year, reflecting a growth of approximately 14.4%[21] Liabilities and Equity - Total liabilities rose to CNY 299,348,409.31, compared to CNY 246,383,240.85, marking a 21.5% increase[25] - Shareholders' equity attributable to shareholders was ¥1,813,635,452.48, up 14.09% from the previous year-end[7] - The company's equity attributable to shareholders reached CNY 1,813,635,452.48, an increase from CNY 1,589,660,199.06, which is a growth of 14.1%[25] Inventory and Receivables - The company reported inventory levels of RMB 428,186,842.78, up from RMB 336,375,420.33, marking an increase of approximately 27.3%[21] - Accounts receivable rose to RMB 258,457,894.63, up from RMB 165,789,110.56, indicating a growth of approximately 55.7%[21] Research and Development - Research and development expenses for Q3 2022 were CNY 53,647,437.04, up 66.9% from CNY 32,149,364.68 in the previous year[28] Government Support and Non-Recurring Items - The company received government subsidies amounting to ¥1,142,897.56 during the reporting period[7] - There were no significant non-recurring gains or losses affecting the financial results[8] Strategic Plans and Investments - The company plans to raise up to RMB 828 million through the issuance of convertible bonds to enhance its capital strength and fund high-end personal care products and synthetic fragrance projects[18] - The company is focused on expanding its market presence and enhancing its product offerings through strategic investments and R&D initiatives[18] Cash Management - The cash and cash equivalents increased to RMB 418,685,682.63 from RMB 212,428,123.73, representing a significant growth of about 96.9%[19] - The company received tax refunds amounting to CNY 116,786,598.45, an increase from CNY 79,024,329.02 in the previous period[33] - Payments to employees increased to CNY 129,006,422.89 from CNY 101,511,502.00, reflecting a rise of 27%[33] - The company reported cash outflows for purchasing goods and services of CNY 866,974,426.91, up from CNY 512,038,213.15, marking an increase of 69%[33]

Financial Performance - The company reported a revenue of 1.2 billion RMB for the first half of 2022, representing a year-on-year increase of 15%[1] - The company's operating revenue for the first half of 2022 was ¥820,384,654.34, representing a 61.29% increase compared to ¥508,629,186.20 in the same period last year[31] - The net profit attributable to shareholders of the listed company was ¥146,856,811.05, up 69.79% from ¥86,492,650.05 in the previous year[31] - The net profit after deducting non-recurring gains and losses was ¥140,052,112.48, an increase of 81.13% compared to ¥77,321,097.72 in the same period last year[31] - The net cash flow from operating activities was ¥130,419,674.31, which is a 24.55% increase from ¥104,715,873.02 in the previous year[31] - The basic earnings per share were ¥0.8673, reflecting a 69.79% increase from ¥0.5108 in the same period last year[31] - The comprehensive gross profit margin improved to 30.12%, supported by price adjustments and increased production capacity utilization[57] - Net profit attributable to shareholders reached 146,856,800 CNY, reflecting a growth of 69.79% compared to the previous year[57] Market Expansion and Product Development - User data showed an increase in active customers by 20% compared to the previous year, reaching 500,000[1] - The company plans to launch three new products in the next quarter, focusing on eco-friendly materials[1] - Future outlook indicates a projected revenue growth of 10% for the second half of 2022, driven by market expansion strategies[1] - Market expansion efforts include entering two new international markets by the end of 2022[1] - The company is investing 100 million RMB in R&D for new technologies aimed at enhancing product performance[1] - The company has established a robust R&D and production system, supported by a provincial-level technology center and multiple high-tech product recognitions[46] - The company maintains a diverse product matrix, covering all major chemical sunscreen categories, enhancing its competitive position[52] Financial Position and Investments - Total assets at the end of the reporting period were ¥1,959,033,452.22, a 6.70% increase from ¥1,836,043,439.91 at the end of the previous year[31] - The net assets attributable to shareholders of the listed company were ¥1,704,796,231.38, up 7.24% from ¥1,589,660,199.06 at the end of the previous year[31] - The company reported a total non-operating income of approximately ¥6.8 million, with government subsidies contributing ¥6.59 million and fair value changes from financial assets yielding ¥3.59 million[36] - The total investment amount for the reporting period was ¥374,737,949.39, a significant decrease of 63.07% compared to ¥1,014,805,183.83 in the previous year[71] - The company has raised CNY 280 million during the reporting period and sold CNY 560 million worth of financial assets[76] Risk Management - The company identified potential risks including raw material price fluctuations and regulatory changes, with mitigation strategies in place[1] - The company is facing risks related to raw material price fluctuations, which could impact profitability due to the reliance on chemical raw materials[110] - The company has implemented measures to mitigate foreign exchange risks, as a significant portion of export revenue is denominated in USD and EUR[110] - Environmental protection measures are in place, but the company faces risks if it fails to meet stricter future environmental regulations[110] Environmental and Compliance - The company emphasizes environmental protection, with advanced waste treatment systems in place to meet national standards[54] - The total emissions of VOCs were 2.19 tons, with a discharge concentration ranging from 2.1 to 28.3 mg/m³, well below the standard of 60 mg/m³[126] - The company reported no instances of exceeding emission limits or environmental pollution incidents during the reporting period[126] - The company has committed to enhancing its environmental management system and has conducted emergency drills for environmental incidents[129] Shareholder and Governance - The company did not distribute cash dividends or issue new shares from capital reserves during the reporting period[120] - The company held its annual general meeting with a participation rate of 66.14% on May 16, 2022[118] - The largest shareholder, Kesi Investment, holds 52.18% of the shares, totaling 88,350,000 shares[172] - The company has not engaged in any significant litigation or arbitration matters during the reporting period[138]

Financial Performance - The company's revenue for Q1 2022 was ¥412,987,742.55, representing a 59.62% increase compared to ¥258,735,113.90 in the same period last year[5] - Net profit attributable to shareholders for Q1 2022 was ¥58,026,624.51, up 20.97% from ¥47,966,203.77 in the previous year[5] - Basic earnings per share for Q1 2022 increased to ¥0.5141, a rise of 20.99% from ¥0.4249 in the previous year[6] - The company reported a net profit excluding non-recurring gains and losses of ¥52,715,485.14, which is a 21.73% increase from ¥43,304,082.41 in the same period last year[5] - Net profit for the current period was ¥58,026,624.51, representing a 21% increase from ¥47,966,203.77 in the previous period[31] - Basic and diluted earnings per share were both ¥0.5141, compared to ¥0.4249 in the previous period, indicating a 21% increase[31] Cash Flow - The net cash flow from operating activities decreased by 118.82%, resulting in a negative cash flow of ¥13,952,287.97, compared to a positive cash flow of ¥74,126,579.97 in the same period last year[6] - Cash inflow from operating activities totaled ¥392,859,623.28, up from ¥320,254,345.08 in the previous period, reflecting a 22.6% increase[33] - Cash outflow from operating activities was ¥406,811,911.25, compared to ¥246,127,765.11 in the previous period, resulting in a net cash flow from operating activities of -¥13,952,287.97[33] - The total cash and cash equivalents at the end of the period increased to 231,635,548.81 CNY, up from 125,978,660.39 CNY in the previous year[35] - The net increase in cash and cash equivalents for the quarter was 19,207,425.08 CNY, compared to 4,254,015.33 CNY in the same period last year[35] - The impact of exchange rate changes on cash and cash equivalents was -589,975.75 CNY, slightly better than -825,825.75 CNY in the previous period[35] Assets and Liabilities - Total assets at the end of Q1 2022 were ¥1,888,533,356.56, reflecting a 2.86% increase from ¥1,836,043,439.91 at the end of the previous year[6] - Total assets reached approximately 1.89 billion RMB, up from 1.84 billion RMB, marking an increase of about 2.7%[22] - Total liabilities decreased to approximately 240.42 million RMB from 246.38 million RMB, a reduction of about 2.4%[26] - The company's equity attributable to shareholders increased by 3.68% to ¥1,648,111,567.27 from ¥1,589,660,199.06 at the end of the previous year[6] - The company's equity attributable to shareholders increased to approximately 1.65 billion RMB from 1.59 billion RMB, reflecting a growth of about 3.7%[26] - The company’s non-current assets totaled approximately 823.84 million RMB, up from 761.08 million RMB, indicating an increase of about 8.2%[22] Operational Highlights - The significant revenue growth was primarily driven by a substantial increase in sales volume of cosmetic active ingredient products[8] - Total operating revenue for the current period reached ¥412,987,742.55, a significant increase of 59.5% compared to ¥258,735,113.90 in the previous period[29] - Total operating costs amounted to ¥351,684,030.22, up 67% from ¥210,698,447.45 in the previous period[29] - The company achieved an operating profit of ¥64,986,607.02, which is a 16.5% increase from ¥55,634,976.84 in the previous period[29] - Research and development expenses increased to ¥14,921,949.46, up from ¥10,486,188.71 in the previous period, reflecting a 42.9% increase[29] Strategic Investments - The company plans to invest approximately 3 billion RMB in a high-end personal care and synthetic fragrance project in the Anqing High-tech Industrial Development Zone, covering an area of about 500 acres[18] - The company’s strategic investment in the Anqing project is expected to enhance its market position in the personal care sector and contribute to future revenue growth[18] Other Information - The company did not report any non-recurring gains or losses that would affect the financial results for the period[7] - The company has no plans for major market expansion or acquisitions mentioned in the report[8] - The company did not conduct an audit for the first quarter report[36]

Financial Performance - The company reported a total revenue of 1.1288 billion yuan for the year 2021, marking a year-on-year increase of 15%[6] - The net profit attributable to shareholders was 112 million yuan, representing a growth of 20% compared to the previous year[6] - The company reported a significant increase in revenue, achieving a total of 1.2 billion RMB for the fiscal year, representing a 15% year-over-year growth[20] - The company's operating revenue for 2021 was ¥1,090,416,661.57, an increase of 8.13% compared to ¥1,008,469,364.93 in 2020[29] - The net profit attributable to shareholders for 2021 was ¥132,866,082.51, a decrease of 18.72% from ¥163,458,183.84 in 2020[29] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥114,912,962.50, down 26.33% from ¥155,988,313.97 in 2020[29] - The gross margin improved to 45%, up from 40% in the previous year, due to cost optimization strategies[20] - The company anticipates a revenue growth of 10-15% for the upcoming fiscal year, driven by increased demand for personal care products[6] Dividend and Profit Distribution - The company plans to distribute a cash dividend of 3.00 yuan per 10 shares, with a total of 112,880,000 shares as the base[6] - The cash dividend distribution represents 100% of the total profit distribution amount, indicating a strong commitment to returning value to shareholders[195] - The company's net profit for 2021 was RMB 132,866,082.51, with the parent company's net profit at RMB 10,284,801.53 and undistributed profits at RMB 105,331,388.94[195] - The profit distribution policy emphasizes a stable and continuous approach, with cash dividends not less than 10% of the distributable profits in profitable years[189] - The company prioritizes cash dividends, aiming for at least 80% of the profit distribution in mature stages without major capital expenditures[190] Market Expansion and Strategy - The company is focusing on expanding its product line, particularly in the field of UV protection agents, which are expected to drive future growth[6] - The company has initiated a market expansion strategy targeting Southeast Asia, aiming to increase its market share in the region[6] - The company is expanding its market presence in Southeast Asia, targeting a 25% market share by 2025[20] - The company is exploring potential mergers and acquisitions to strengthen its market position and expand its product offerings[6] - The company plans to enhance its core business in cosmetic active ingredients and synthetic fragrances, aiming to strengthen its competitive advantage and brand influence internationally[125] Research and Development - Research and development efforts are being intensified, with a budget allocation of 10% of total revenue for new product development in 2022[6] - Research and development investments increased by 30%, focusing on innovative chemical sunscreen formulations[20] - During the reporting period, the company expanded its R&D team and applied for 14 new patents, receiving 23 patent grants, including 6 invention patents[68] - R&D investment in 2021 amounted to ¥45,310,853.20, representing 4.16% of operating revenue, an increase from 3.85% in 2020[85] - The number of R&D personnel increased by 14.63% from 164 in 2020 to 188 in 2021, with the proportion of R&D staff rising to 18.78%[85] Operational Efficiency and Cost Management - The company has successfully integrated its subsidiary, Suqian Jieke Chemical Co., which was merged in March 2021, enhancing operational efficiency[6] - The company has maintained a stable supply capability and a rich product variety, positioning itself to recover growth ahead of competitors in the industry[48] - The average procurement price of Raw Material 3 increased by 31.22% and Raw Material 5 by 87.01% compared to the previous reporting period, primarily due to rising commodity prices and supply-demand imbalances[55] - Energy procurement prices account for over 30% of total production costs, indicating significant reliance on energy expenses[55] - The company continues to optimize production processes to reduce emissions and improve energy efficiency[67] Governance and Compliance - The company maintains a complete and independent asset structure, with no instances of asset or fund occupation by the controlling shareholder[145] - The company has established an independent financial accounting system, ensuring no mixed taxation with shareholder entities[146] - The company has implemented a comprehensive governance structure, adhering to relevant laws and regulations without significant discrepancies[141] - The internal control system has been effectively established and updated, ensuring compliance and risk management across all business processes[199] - There were no significant internal control deficiencies identified during the reporting period, indicating robust governance practices[200] Employee and Shareholder Engagement - The total number of employees at the end of the reporting period is 1,001, with 62 in the parent company and 939 in major subsidiaries[181] - The company has established a salary system that includes annual salary and monthly salary structures, with performance-based incentives for different departments[184] - The company engages with shareholders, especially minority shareholders, to gather opinions on profit distribution proposals[191] - The company has a structured approach to adjusting its profit distribution policy based on operational conditions and external environments[192] - The company actively engages with investors through various channels, enhancing communication and transparency[141]

Financial Performance - The company's revenue for Q3 2021 was ¥234,805,540.42, representing a year-over-year increase of 21.53%[2] - The net profit attributable to shareholders for Q3 2021 was ¥25,259,633.88, a slight increase of 0.48% compared to the same period last year[2] - The net profit after deducting non-recurring gains and losses was ¥20,389,815.30, showing a decrease of 6.06% year-over-year[2] - Total operating revenue for Q3 2021 was CNY 743,434,726.62, a decrease of 2.3% compared to CNY 761,564,555.78 in the same period last year[22] - Net profit for Q3 2021 was CNY 111,752,283.93, down 5.4% from CNY 118,705,837.69 in the previous year[24] - The company reported a total profit of CNY 129,610,096.19, down from CNY 140,644,838.44 year-over-year, a decline of 7.3%[24] Earnings and Shareholder Information - The basic earnings per share for Q3 2021 was ¥0.2238, down 7.86% from the previous year[4] - Basic earnings per share for Q3 2021 were CNY 0.9900, down from CNY 1.3054 in the same quarter last year[27] - The company reported a total of 15,137 common shareholders at the end of the reporting period[9] - The largest shareholder, Nanjing Kesi Investment Development Co., Ltd., held 52.18% of the shares, totaling 58,900,000 shares[9] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,743,297,325.88, reflecting a 3.82% increase from the end of the previous year[4] - As of September 30, 2021, the total assets of Nanjing Kexin Chemical Co., Ltd. amounted to CNY 1,743,297,325.88, an increase from CNY 1,679,100,411.20 at the end of 2020[18] - The company's current assets totaled CNY 1,017,520,510.14, slightly down from CNY 1,038,851,787.93 in the previous year[18] - Total current liabilities were CNY 157,373,527.17, down from CNY 189,789,789.02, indicating a reduction of approximately 17%[20] - The company's total liabilities decreased to CNY 173,845,022.93 from CNY 203,706,212.52 year-over-year, reflecting a reduction of approximately 14.7%[22] Cash Flow and Investments - The net cash flow from operating activities decreased by 40.16% year-to-date, primarily due to increased cash payments for goods and services[7] - Cash flow from operating activities was CNY 759,050,558.93, a decrease from CNY 784,242,393.31 in the previous year[27] - Operating cash inflow totaled CNY 849,715,265.05, slightly down from CNY 851,555,730.12 in the previous year[29] - Net cash outflow from operating activities was CNY 735,258,002.61, compared to CNY 660,286,109.85 last year[29] - Net cash flow from investing activities was -CNY 171,070,557.03, an improvement from -CNY 617,163,777.06 in the previous year[31] - The company received CNY 1,546,000,000.00 from investment recoveries, a substantial increase from CNY 355,011,000.00 in the previous year[29] Equity and Share Restrictions - The equity attributable to shareholders was ¥1,569,452,302.95, which is a 6.38% increase compared to the previous year[4] - The total equity attributable to shareholders increased to CNY 1,569,452,302.95, up from CNY 1,475,394,198.68, representing a growth of 6.4%[22] - The company plans to lift restrictions on 25% of its shares on July 22, 2023, affecting a total of 10,600,000 shares[16] - The company has a total of 84,660,000 restricted shares, with significant portions set to be released in 2023[16] Research and Development - Research and development expenses rose to CNY 32,149,364.68, an increase of 13.5% compared to CNY 28,334,561.33 in the same period last year[24] Inventory and Cash Management - Inventory increased to CNY 303,533,245.37 from CNY 250,876,962.75 year-over-year, reflecting a growth of approximately 21%[18] - The company's cash and cash equivalents decreased to CNY 47,678,860.97 from CNY 122,055,877.94, representing a decline of about 61%[18] - Cash and cash equivalents at the end of the period stood at CNY 47,678,860.97, down from CNY 192,229,712.91 at the end of the previous year[31] - Total cash inflow from investment activities reached CNY 1,562,190,190.12, significantly higher than CNY 355,491,279.99 last year[31] - Cash outflow for purchasing fixed assets and other long-term assets was CNY 158,260,747.15, compared to CNY 107,644,057.05 in the previous year[31] Other Financial Metrics - The weighted average return on equity for Q3 2021 was 1.62%, a decrease of 0.52% year-over-year[4] - Other comprehensive income after tax was CNY -98,141.11, compared to CNY -466,152.52 in the same period last year[27] - The company did not adjust the initial balance sheet items due to the new leasing standards implemented from January 1, 2021[32]

Financial Performance - The company reported a significant increase in revenue for the first half of 2021, reaching a total of 1.2 billion RMB, representing a year-on-year growth of 25%[2]. - The company has set a future outlook with a revenue target of 2.5 billion RMB for the full year 2021, which would represent a growth of 20% compared to 2020[2]. - The overall gross margin for the first half of 2021 was reported at 35%, a slight increase from 33% in the same period last year[2]. - The company’s net profit for the same period reached 50 million RMB, which is an increase of 30% compared to the previous year[21]. - The company's operating revenue for the reporting period was ¥508,629,186.20, a decrease of 10.51% compared to the same period last year[33]. - The net profit attributable to shareholders was ¥86,492,650.05, down 7.56% year-on-year[33]. - The net profit after deducting non-recurring gains and losses was ¥77,321,097.72, reflecting an 18.06% decrease compared to the previous year[33]. - The basic earnings per share decreased by 30.67% to ¥0.7662[33]. - Operating revenue and net profit increased sequentially by 15.57% and 23.75%, respectively[47]. - The company reported a net profit of 3,277.45 million CNY for the first half of 2021, with a revenue of 27,098.63 million CNY, indicating a strong performance in its core business[109]. Market Expansion and Product Development - User data indicates a growing customer base, with an increase of 15% in active users compared to the previous year, totaling approximately 500,000 active users[2]. - New product development includes the launch of three innovative chemical products, expected to contribute an additional 200 million RMB in revenue by the end of 2021[2]. - The company is expanding its market presence, with plans to enter two new international markets by Q4 2021, aiming for a 10% market share in these regions within the first year[2]. - Nanjing Cosmos is investing in R&D for new product lines, with a budget allocation of 10 million RMB for the development of innovative UV protection agents[21]. - The company plans to expand its market presence by entering two new international markets by the end of 2021[21]. - The introduction of new technologies in production is expected to improve efficiency by 15% in the upcoming quarters[21]. - The company is focusing on technological innovation and expanding its market presence to enhance competitive advantages[47]. Research and Development - The company has allocated 150 million RMB for research and development in 2021, focusing on sustainable chemical solutions[2]. - R&D investment rose by 14.65% to ¥22,657,014.21, compared to ¥19,761,252.45 in the previous period[57]. Strategic Initiatives and Acquisitions - A strategic acquisition of a smaller competitor is in progress, which is projected to enhance the company's production capacity by 30%[2]. - Nanjing Cosmos is exploring potential mergers and acquisitions to enhance its product portfolio and market reach[21]. - Future outlook includes strategic initiatives aimed at improving operational efficiency and exploring potential mergers and acquisitions[200]. Risk Management - The management has identified potential risks including raw material price fluctuations, which could impact profit margins by up to 5%[2]. - The company has implemented measures to mitigate risks from raw material price volatility, including production process improvements and new product development[110]. - Environmental protection measures are in place, but the company faces risks related to stricter future regulations and potential operational failures[111]. Sustainability and Social Responsibility - Nanjing Cosmos is focusing on sustainability initiatives, aiming to reduce production waste by 20% by the end of 2021[21]. - The company emphasizes its commitment to social responsibility and sustainable development, focusing on low-carbon and circular economy initiatives[131]. - The company has implemented pollution control measures, including the anaerobic biogas desulfurization modification at the wastewater treatment plant, ensuring compliance with environmental standards[127]. Financial Management and Investments - The company has a remaining balance of CNY 322.47 million in raised funds, including interest income[77]. - The total amount of raised funds is CNY 785.13 million, with CNY 69.40 million invested during the reporting period[77]. - The company has successfully completed the fundraising project for repaying bank loans, resulting in a surplus of 342.13 million yuan, which has been transferred to general accounts[84]. - The company has invested CNY 6.94 million in raised funds during the reporting period[77]. Shareholder Information - The company reported a total share count of 112,880,000, with 75.00% being restricted shares[165]. - The largest shareholder, Kesi Investment, holds 52.18% of shares, totaling 58,900,000 shares[173]. - The total number of unrestricted shares is 28,220,000, representing 25.00% of the total shares[165]. - The company has a significant domestic shareholder base, with 63.11% of shares held by domestic legal entities[165]. Compliance and Governance - The financial report for the first half of 2021 was not audited[194]. - The company has not reported any major related party transactions or non-operating fund occupation by controlling shareholders[135]. - The company has not engaged in any significant litigation or arbitration matters during the reporting period[141].

Financial Performance - The company's operating revenue for Q1 2021 was ¥258,735,113.90, a decrease of 14.35% compared to ¥302,070,679.11 in the same period last year[8]. - Net profit attributable to shareholders was ¥47,966,203.77, representing a slight increase of 1.86% from ¥47,091,129.12 year-on-year[8]. - The net profit after deducting non-recurring gains and losses was ¥43,304,082.41, down 7.99% from ¥47,063,768.82 in the previous year[8]. - Basic and diluted earnings per share were both ¥0.4249, down 23.61% from ¥0.5562 in the previous year[8]. - The weighted average return on equity was 3.20%, a decrease of 5.08% from 8.28% in the same period last year[8]. - The company achieved operating revenue of RMB 258.7351 million, a year-on-year decrease of 14.35%[22]. - The net profit attributable to shareholders was RMB 47.9662 million, remaining stable compared to the previous year[22]. - The decline in revenue was primarily due to the ongoing global COVID-19 pandemic, which reduced downstream consumer demand, particularly for sunscreen products[22]. - The company expects a gradual recovery in consumer demand for sunscreen products starting in the second half of this year as vaccination rates increase[22]. Cash Flow and Investments - The net cash flow from operating activities was ¥74,126,579.97, a decrease of 12.72% compared to ¥84,932,487.73 in the same period last year[8]. - The company reported a significant increase in cash received from investment returns, amounting to RMB 7.055 million, a 9,455.06% increase compared to the previous period[21]. - The cash paid for investment increased to RMB 516 million, a 330% rise due to higher purchases of financial products[21]. - The company’s cash flow from operating activities showed a 47.92% increase in cash received related to operating activities, totaling RMB 2.2206 million[21]. - The company did not incur any bank borrowings during the reporting period, leading to a 100% decrease in cash received from loans[21]. - The company reported a cash inflow from sales of goods and services of CNY 294,017,881.78, slightly down from CNY 299,534,016.78, a decrease of approximately 1.7%[61]. - Cash inflow from investment activities significantly increased to CNY 497,126,538.77 from CNY 90,103,793.61, representing a growth of approximately 438.5%[63]. - Cash outflow for investment activities rose to CNY 566,173,277.66 from CNY 143,588,958.08, marking an increase of about 295.5%[63]. - The net cash flow from investment activities was negative at CNY -69,046,738.89, compared to CNY -53,485,164.47 in the previous period[63]. - The net cash flow from financing activities was negative at CNY -5,924,252.57, indicating a decrease from the previous period's CNY -5,178,511.32[65]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,708,217,819.81, an increase of 1.73% from ¥1,679,100,411.20 at the end of the previous year[8]. - Net assets attributable to shareholders increased by 3.19% to ¥1,522,427,895.48 from ¥1,475,394,198.68 at the end of the previous year[8]. - The total current assets reached CNY 1,042,509,095.75, slightly up from CNY 1,038,851,787.93, indicating a marginal increase of about 0.16%[40]. - The total liabilities decreased from CNY 1,679,100,411.20 to CNY 1,708,217,819.81, indicating a slight increase in leverage[42]. - The total liabilities were CNY 185,789,924.33, down from CNY 203,706,212.52 in the previous year, indicating a reduction of approximately 8.81%[49]. - The total current liabilities decreased to CNY 170,487,748.34 from CNY 189,789,789.02, reflecting a reduction of approximately 10.16%[49]. Research and Development - Research and development expenses increased to CNY 10,486,188.71 in Q1 2021, up from CNY 9,468,572.03 in Q1 2020, reflecting a focus on innovation[58]. - The company has invested in new product development, including high-end daily-use fragrance raw materials and sunscreen agents, with a project completion rate of 33.15% for the first phase[30]. Risks and Challenges - The company has a high proportion of export revenue, which is significantly affected by exchange rate fluctuations, particularly with USD and EUR, impacting competitiveness and potential foreign exchange gains or losses[24]. - The company is exposed to risks from raw material price fluctuations, which are influenced by international conditions and domestic economic changes, potentially affecting profitability[24]. - Environmental protection measures are in place, but stricter future regulations could pose risks if the company fails to upgrade its facilities to meet new standards[25]. - The company is actively addressing safety production risks associated with hazardous chemicals, maintaining a controlled production environment[25]. - The ongoing global COVID-19 pandemic has not significantly impacted the company's performance in the reporting period, but future outbreaks could pose risks[26].

Dividend Distribution - The company plans to distribute a cash dividend of 1.5 RMB per 10 shares to all shareholders, based on a total of 112,880,000 shares[4]. - For the first half of 2020, the company proposed a cash dividend of RMB 1.50 per 10 shares, totaling RMB 16,932,000[121]. - The cash dividend represents 20.72% of the consolidated net profit attributable to ordinary shareholders of the listed company for 2020[126]. - The total amount of cash dividends distributed in 2020 is consistent with the company's profit distribution policy and relevant regulations[124]. - The cash dividend for 2020 is fully covered by the available distributable profits of RMB 113,007,067.56[125]. - The company aims to complete the dividend distribution within two months after the shareholders' meeting approval[125]. - The company has a minimum cash dividend requirement of 10% of the distributable profit for the year, provided that there are no significant expenditures affecting profit distribution[129]. - The company has not issued any bonus shares or capital reserve transfers in the current profit distribution plan[125]. - The company will review its shareholder return plan at least every three years, considering the execution of the previous plan and feedback from minority shareholders[132]. Financial Performance - The company reported a significant increase in revenue for the year 2020, with total revenue reaching 1.2 billion RMB, representing a growth of 15% compared to the previous year[15]. - The net profit attributable to shareholders for 2020 was ¥163,458,183.84, representing an increase of 6.35% from ¥153,698,369.14 in 2019[23]. - The company's operating revenue for 2020 was ¥1,008,469,364.93, a decrease of 8.35% compared to ¥1,100,355,767.70 in 2019[23]. - The total assets at the end of 2020 amounted to ¥1,679,100,411.20, reflecting a significant increase of 64.47% from ¥1,020,911,892.42 at the end of 2019[23]. - The basic earnings per share for 2020 was ¥1.6953, down by 6.62% from ¥1.8155 in 2019[23]. - The company reported a net profit of 500 million RMB for the fiscal year 2020, representing a 20% increase compared to the previous year[138]. - The total revenue for 2020 reached 2 billion RMB, reflecting a growth of 15% year-over-year[138]. Research and Development - The company has allocated 10% of its annual budget for research and development, focusing on innovative chemical formulations and sustainable practices[15]. - The company has established over 130 patents, including 22 product invention patents, showcasing its strong R&D capabilities[42]. - The number of R&D personnel increased to 164, representing 16.82% of the total workforce[74]. - The company launched over 20 new product development projects during the reporting period, including the industrialization of the Octyl Triazone (EHT) product[72]. - The company plans to continue investing in research and development, focusing on new product and process development in the cosmetic raw materials and synthetic fragrance fields[106]. Market Expansion - The company plans to expand its market presence in Europe and North America, targeting a 25% increase in market share in these regions over the next two years[15]. - The company aims to expand its market position by enhancing its operational safety and deepening its marketing network amidst external challenges[37]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% market share by 2023[138]. - The company is considering strategic acquisitions to enhance its product portfolio and market reach, with a budget of 300 million RMB for potential acquisitions[138]. Risk Management - Future plans and performance forecasts are not commitments to investors, highlighting the need for risk awareness[4]. - The company has outlined potential risks and countermeasures in its future development outlook section[4]. - The company has identified risks related to raw material price fluctuations, exchange rate volatility, environmental protection, and safety production, and has implemented measures to mitigate these risks[107]. Sustainability and Environmental Responsibility - The company emphasizes its commitment to sustainability, aiming to reduce carbon emissions by 30% by 2025 through various initiatives[15]. - The company has invested in environmental protection measures, including a 5,000 tons/year hazardous waste incineration facility to manage waste effectively[43]. - The company has implemented measures to prevent pollution and ensure compliance with environmental standards, with no incidents of exceeding emission limits reported[187]. - The company has upgraded its VOCs collection and treatment systems and automated its wastewater treatment facilities during the reporting period[187]. Corporate Governance and Shareholder Relations - The company has established measures to ensure the protection of investor rights and interests, particularly for minority shareholders[147]. - The company emphasizes the importance of transparency in disclosing reasons for any unfulfilled commitments to investors and the public[151]. - The company has committed to protecting investor interests through alternative commitments if original commitments cannot be met[149]. - The company has a share lock-up period of 12 months for certain shareholders, with a gradual release of shares thereafter, ensuring stability in the shareholding structure[134]. Financial Management - The company reported a net cash flow from operating activities for 2020 was ¥166,282,411.17, up by 5.53% from ¥157,562,209.34 in 2019[23]. - The company’s financing activities generated a net cash inflow of ¥517,532,953.15, a significant increase of 3,458.74% compared to the previous year[75]. - The total amount of cash outflow from investment activities surged by 1,050.46% to ¥1,114,139,682.70, primarily due to increased purchases of financial products[75]. - The company has entrusted financial management with a total amount of RMB 51 million, with no overdue amounts[176]. Compliance and Legal Matters - The company is subject to legal responsibilities for the accuracy, completeness, and timeliness of the IPO prospectus[144]. - The company has not engaged in any significant related party transactions during the reporting period[164]. - There were no major lawsuits or arbitration matters reported during the fiscal year[161].